Sales rise 18.78% to Rs 83.69 crore
Net profit of Hester Biosciences rose 100.49% to Rs 8.20 crore in the quarter ended September 2024 as against Rs 4.09 crore during the previous quarter ended September 2023. Sales rose 18.78% to Rs 83.69 crore in the quarter ended September 2024 as against Rs 70.46 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales83.6970.46 19 OPM %22.8918.75 -PBDT16.0711.05 45 PBT11.876.76 76 NP8.204.09 100Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Donald Trump, Trump")
 "share market")
 "Lucknow Super Giants' most likely retained players")
 "Diwali")
 "BSE, stock market")
